Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell 5Recurrence 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Prolymphocytic, T-Cell 2Immunoblastic Lymphadenopathy 2Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Lymphoid 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Hodgkin Disease 1Head and Neck Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Cyclophosphamide 7fludarabine phosphate 5fludarabine 4Whole-Body Irradiation 4Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4ibrutinib 3Mycophenolic Acid 3Mesna 3Busulfan 3pirtobrutinib 2Patient Reported Outcome Measures 2Melphalan 2Bone Marrow Transplantation 2Biopsy 2venetoclax 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1duvelisib 1Thiotepa 1Surveys and Questionnaires 1Social Determinants of Health 1Sirolimus 1Receptors, Chimeric Antigen 1Methotrexate 1Leukapheresis 1Immunotherapy, Adoptive 1Cyclosporins 1Cyclosporine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Lymphoid × duvelisib × 1 year × Clear all
NCT05065866 2025-12-04

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
14 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡